Skye Bioscience appoints Puneet Arora as Chief Medical Officer, grants 225,000 stock options

Skye Bioscience, Inc.

Puneet S. Arora, MD, appointed CMO effective Sept 3, 2024; base salary $475k with 40% target bonus.
Received inducement stock option for 225k shares vesting over 4 years (25% at 1-year, then monthly).
Previously CMO at Lassen Therapeutics, Head of Clinical Dev at Principia (Sanofi), Senior Medical Director at Genentech.
Company focuses on Phase 2 CBeyond obesity trial for nimacimab, a CB1 inhibitor.
Also granted 13,500 share non-qualified option to a new non-executive employee under inducement plan.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Puneet S. Arora

Chief Medical Officer

SKYE · Skye Bioscience, Inc.

Effective: 2024-09-03
Filed: September 4, 2024, 7:59 PM ET

On September 3, 2024, Skye Bioscience, Inc. (the “Company”) announced the appointment of Puneet S. Arora, MD, MS, FACE, as Chief Medical Officer, effective as of September 3, 2024 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Puneet S. Arora was appointed as Chief Medical Officer at Skye Bioscience, Inc..

Action: appointed
Role: Chief Medical Officer

Exact text from the filing

On September 3, 2024, Skye Bioscience, Inc. (the “Company”) announced the appointment of Puneet S. Arora, MD, MS, FACE, as Chief Medical Officer, effective as of September 3, 2024 (the “Effective Date”).

View on SEC.gov

Skye Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001516551-24-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.